Sign in
CompletedNo phase

Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH

Key facts

Who runs it
University of Zurich
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
70 people, planned
Started
Jun 2015
Ended
Dec 2024
Type of study
Interventional
Treatments tested
  • Gait analysis and MRI:
Record updated
30 April 2026

Who can take part

Age
50 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Informed consent
  • Age 50 years or above
  • Impaired walking function for at least 3 months, onset at/ after 40 years of age
  • MRI or CT with enlarged ventricular system (Evans' index ≥0.30) without evidence of moderate or severe cortical atrophy
  • Eligible for shunt surgery
  • Eligible for analysis of gait, neuropsychological and urological function
  • Subjects must be able to understand the patient information sheet and comply with the requirements of the protocol

Who cannot take part

  • Previous intracranial disorder or surgery
  • Contraindications to surgery or MRI
  • Presence of concomitant disease which might reasonably account for the clinical symptoms or radiological findings
  • Worsening of walking function secondary to any other condition occurring during the study
  • Contraindications to the testing of gait, bladder or neuropsychological function

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

INPH is a chronic, progressive disease characterised by enlarged ventricles in the absence of elevated intracranial pressure. Patients often present with the Hakim triad comprising gait disturbance, dementia and urinary incontinence. Treatment consists of ventriculoperitoneal (VP) shunting reducing the cerebrospinal fluid (CSF) volume in the central nervous system (CNS); a generally safe and well tolerated procedure nevertheless invasive in nature and associated with surgical risk. The currently used diagnostic algorithms to predict surgery outcome by testing patients before and after a diagnostic spinal tap temporarily reducing the CSF volume in the CNS are of wide variability and limited validity. Developing measures to accurately diagnose and select patients for intervention is thus of great importance. The objective of this study is to define and validate a diagnostic algorithm for the selection of patients with symptoms compatible with iNPH for shunt surgery.

The group in the trial

  • Gait analysis and MRIOther group

    * Gait analysis: Intervention: Treadmill with pressure sensors (FDM-THM-M-System (Force distribution method-treadmill); 'Zebris' medical GmbH), study-specific, but routine procedures. * MRI: Intervention: Performed in a scanner at the University Hospital with standard MRI compatibility procedures; study specific is only the additional MRI after the CSF release with spinal tap or drainage.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective Single-centre Trial Investigating Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With Idiopathic Normal Pressure Hydrocephalus
Record updated
30 April 2026